References
- Creinin MD, Moyer R, Guido R. Misoprostol for medical evacuationof early pregnancy failure.Obstet Gynecol 1997;89; 768�72
- Chung TKH, Chung LP, Leung TY, et al. Misoprostol in the management of spontaneous abortion. Br J Obstet Gynaecol 1995;102:832�5
- Ayres-de-Campos D, Teixeira-da-Silva J, Campos I, et al. Vaginal misoprostol in the management of first trimester abortions. Int J Gynecol Obstet 2000;71:53�7
- Singh K, Fong YF. Preparation of the cervix for surgical termination of pregnancy in the first trimester. Hum Reprod Update 2000;6:442�8
- El Refaey H, Calder L, Wheatley DN, et al. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 1994;343:1207�9
- Sanchez RL, Kaunitz AM, Wears RL, et al. Oral or vaginal misoprostol for induction of labor. Int J Gynecol Obstet 1997; 56:135�9
- Mundle W, Young D. Vaginal misoprostol for induction of labor: a randomized controlled trial. Obstet Gynecol 1998; 88:521�5
- Wing DA, Paul RH. A comparison of differing dosing regimens of vaginal administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1996;175:158�64
- Song J. Use of misoprostol in obstetrics and gynecology. Obstet Gynecol Surv 2000;55:503�10
- Gonzales CH, Marques-Dias MJ, Kim CA, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 1998; 351:1624�7
- Eng NS, Guan AC. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient for second trimester missed abortion. Aust NZ J Obstet Gynecol 1997; 37:331�4
- BamigboyeAA, Holfmeyr GJ, MerrellDA. Rectalmisoprostol in the prevention of postpartum hemorrhage. A placebo controlled trial. Am J Obstet Gynecol 1998;179:1043�6
- O�Brien P, El- Rafaey H, Gordon E. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrin, a descriptive study. Obstet Gynecol 1998;92:212�14
- Orioli M, Castilla EE. Epidemiological assessment of misoprostol teratogenicity. Br J Obstet Gynaecol 2000;107:519�23
- Coelho KE, Sarmento MF, Veiga CM, et al. Misoprostol embryotoxicity. Clinical evaluation of fifteen patients with arthrogryposis.Am J Med Genet 2000;95:297�301
- Gonzales CH, Vargos FR, Perez AB, et al. Limb deficiency with or without Mobius sequence in severe Brazilian children associated with misoprostol use in the first trimester of pregnancy.Am J Med Genet 1993;47:59�64
- Pastuszak AL, Schuler L, Speck-Martins CE, et al. Use of misoprostol during pregnancy and Mobius syndrome in infants. N Engl J Med 1998;338:1881�5
- Blanch G, Quenby S, Ballantyne ES, et al. Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester: observational study. Br Med J 1998;316:1712�13
- Lemancewicz A, Urban R, Skotnicki MZ, et al. Uterine and fetal Doppler flow changes after misoprostol and oxytocin therapy for induction of labor in postterm pregnancies. Int J GynecolObstet 1999;67;139�45
- Urban R, Lemancewicz A, Urban J, et al. Misoprostol and dinoprostone therapy for labor induction: a Doppler comparison of uterine and fetal hemodynamic effects. Eur J Obstet Gynecol Reprod Biol 2003;19:20�4
- Yip SK, Tse AO, Haines CJ, et al. Misoprostol�s effect on uterine arterial blood flow and fetal hheart rate in early pregnancy.Obstet Gynecol 2000;95:232�5